BPA Call 36C24625A0011-36C24625N0293

Award Date 10/1/24
Potential Completion Date 9/30/25
Potential Value $333K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Emigration Canyon, UT 84108, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Veterans Integrated Service Network 23 (VISN 23) of the U.S. Department of Veterans Affairs to Biomerieux Inc., a global leader in in vitro diagnostics. The $930,018.60 Blanket Purchase Agreement (BPA) call order is for the delivery of test kit reagents, with an ultimate completion date of September 30, 2025. The contract is a firm-fixed-price vehicle under the General Services Administration (GSA) Federal Supply Schedule for In Vitro Diagnostics,...
This is a federal contract award to Biomerieux Inc., a global leader in in vitro diagnostics, for the provision of microbiological testing supplies. The contract, valued at $90,406.54, was awarded by the Veterans Integrated Service Network 21 (VISN 21), a division of the Department of Veterans Affairs. The contract is a firm-fixed-price purchase order without any set-aside designation. Biomerieux, through its Biomerieux, Inc. division, will deliver a range of specialized diagnostic equipment,...
This federal contract award is for the delivery of test kit reagents to the Veterans Integrated Service Network 23 (VISN 23), which is part of the U.S. Department of Veterans Affairs (VA). The prime contractor is Biomerieux Inc., a global leader in in vitro diagnostics. The contract has a ceiling value of $284,029.12 and is a Blanket Purchase Agreement (BPA) Call under Biomerieux's Federal Supply Schedule (FSS) contract for In Vitro Diagnostics, Reagents, and Test Kits. This contract does not...
This federal contract award to Biomerieux Inc. is for the delivery of test kit reagents. The contract has a ceiling value of $224,551.12 and a completion date of September 30, 2025. The contract is a Blanket Purchase Agreement (BPA) call under the General Services Administration (GSA) Federal Supply Schedule for In Vitro Diagnostics, Reagents, and Test Kits. The funding agency is the Veterans Integrated Service Network 23, a division of the Department of Veterans Affairs. Biomerieux Inc. is a...
This federal contract award was made by the Veterans Integrated Service Network 16 (VISN16) to Biomerieux Inc., a global leader in in vitro diagnostics, for automated microbiological blood culture testing equipment, reagents, and supplies. The contract, a Blanket Purchase Agreement (BPA) call with a ceiling value of $58,915.18, has a firm-fixed-price pricing type and an ultimate completion date of September 30, 2022. Biomerieux Inc. will provide its proprietary diagnostic platforms, such as...
This federal contract award to Biomerieux Inc., a global leader in in vitro diagnostics, is for the provision of multiplex PCR reagents and consumables. The contract has a ceiling value of $183,970.60 and a period of performance through September 30, 2025. It is a Blanket Purchase Agreement (BPA) call under Biomerieux's existing Federal Supply Schedule (FSS) contract for In Vitro Diagnostics, Reagents, and Test Kits. This allows various government agencies, including the Department of...
This is a firm-fixed-price definitive contract awarded by the Veterans Integrated Service Network 8 (VISN 8), a component of the U.S. Department of Veterans Affairs (VA), to Biomerieux Inc. for a "COST PER TEST" requirement. The contract has a ceiling value of $191,357.44 and a period of performance through July 3, 2018. Biomerieux Inc., through its Biomerieux, Inc. division, is a global leader in in vitro diagnostics and provides a wide range of clinical diagnostic equipment,...
This federal contract award is for a Blanket Purchase Agreement (BPA) call by the Department of Veterans Affairs (VA) awarded to Biomerieux Inc., a global leader in in vitro diagnostics. The $204,453.39 contract is for the provision of microbiology molecular diagnostic products, including the company's proprietary VITEK, BioFire, and VIDAS platforms, which are widely used for rapid and accurate pathogen detection and identification across government healthcare operations. The contract is not...
This federal contract award to Biomerieux Inc., through its Biomerieux, Inc. Division, is for the provision of multiplex PCR reagents and consumables. The contract has a ceiling value of $87,381.60 and a period of performance ending on September 30, 2025. It is a Blanket Purchase Agreement (BPA) call under the Federal Supply Schedule (FSS) contract for In Vitro Diagnostics, Reagents, and Test Kits. The funding agency is the Veterans Integrated Service Network 12, a civilian agency within the...
This federal contract award was made by the Veterans Integrated Service Network 6 (VISN 6), a division of the U.S. Department of Veterans Affairs, to Biomerieux Inc. through its Biomerieux, Inc. division. The contract, valued at $172,558.82, is for the procurement of RICHMOND FILMARRAY TEST KITS. This is a firm-fixed-price Blanket Purchase Agreement (BPA) call under the Federal Supply Schedule (FSS) contract for In Vitro Diagnostics, Reagents, and Test Kits (FSS-65-VII). The contract has an...

This federal contract award is for $332,845.84 to Biomerieux Inc. through its Biomerieux, Inc. Division. The contract is a Blanket Purchase Agreement (BPA) Call under the Federal Supply Schedule (FSS) 65-VII for In Vitro Diagnostics, Reagents, and Test Kits. The contract is for "SALISBURY TEST KITS" and has an ultimate completion date of September 30, 2025. The award was made by the Veterans Integrated Service Network 6 (VISN 6), a civilian agency within the Department of Veterans Affairs. The contract does not have a set-aside designation. Biomerieux Inc. is a global leader in in vitro diagnostics, providing a range of clinical diagnostic equipment, reagents, and supplies to various federal agencies. The contract likely involves the supply of Biomerieux's proprietary testing platforms and consumables to support infectious disease testing and pathogen detection across VA healthcare operations.

Generated 2/28/25, 9:47 AM